Company / Free Cash Flow per Share
CRESCENT BIOPHARMA, INC. Free Cash Flow per Share History
FY2014-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow per Share
-$71.13
FY2025
5-year range
-$71.13 / -$0.24
FY2021-FY2025
Trend
-19331.6%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Free Cash Flow per Share changed -19332% YoY in FY2025, a notable deviation from the 4-year average annual change of -4807%.
Based on SEC 10-K filings.
-71.13 in FY2025.
Declined from $-0.24 to $-71.13 over the past 9 years.
Free Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, free cash flow per share decreased 19331.6% year-over-year.
- Peak free cash flow per share was recorded in FY2016.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 0.35 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$71.13 | -19331.6% |
| FY2017 | -$0.37 | -55.2% |
| FY2016 | -$0.24 | +71.4% |
| FY2015 | -$0.82 | +89.1% |
| FY2014 | -$7.56 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026